HOW TIL THERAPY
ACTUALLY WORKS
A step-by-step breakdown of what happens from tumor biopsy to cell infusion โ and what patients should realistically expect at each stage.
The TIL Therapy Process โ Step by Step
TIL therapy is a sequence: each stage sets up the next. You cannot skip phase three because you are in a hurry.
- 1
Tumor Tissue Collection
A surgeon removes a small tumor biopsy. The tissue is immediately preserved and sent to a GMP-certified manufacturing facility โ the biological starting point for the entire therapy.
- 2
Cell Extraction & Lab Expansion
Scientists isolate TIL cells from the tumor tissue, culture them with interleukin-2, and prioritize the cells showing strongest tumor reactivity. A starting population of millions becomes tens of billions.
- 3
Lymphodepletion Chemotherapy
A 5โ7 day inpatient chemotherapy regimen depletes existing immune cells to create space for the incoming TIL cells. This is not aimed at the tumor โ it prepares the immune environment.
- 4
TIL Cell Infusion
Billions of expanded TIL cells are delivered intravenously. The infusion itself resembles a blood transfusion. Patients are already admitted to hospital at this point.
- 5
IL-2 Support & Recovery
Interleukin-2 is given in the days after infusion to sustain the TIL cells. This causes significant but manageable side effects โ fever, low blood pressure, fatigue โ monitored in hospital.
Key Timeline Facts
- 4โ6 wksBiopsy to InfusionTotal elapsed time from tissue collection to TIL cell infusion under best conditions.
- 24 hrsInfusion Window After ChemoTIL cells must be infused within 24 hours of completing lymphodepletion โ a biologically time-sensitive window.
- 6โ8 wksFirst Response AssessmentImaging scans to evaluate tumor response are typically performed 6โ8 weeks post-infusion.
What Happens After the Infusion
Patients remain admitted โ typically ten to fourteen days โ while the team monitors for complications and manages IL-2 side effects. The immune system begins rebuilding as TIL cells engraft.
In-Hospital Monitoring
Round-the-clock monitoring for IL-2 toxicities: fever, fluid shifts, blood pressure drops. Experienced centers manage these routinely โ they are expected, not alarming.
Response Assessment
Imaging at 6โ8 weeks determines whether the tumor responded. Some patients show partial responses; some show complete disappearance of measurable disease. Some do not respond.
Conditioning Chemotherapy vs Regular Cancer Chemotherapy
Patients understandably confuse the lymphodepletion step with standard cancer chemotherapy. They share some drug classes but have completely different goals.
Lymphodepletion (Before TIL)
- Goal: clear immune spaceDepletes lymphocytes to make room for incoming TIL cells โ not to attack the tumor.
- Short duration5โ7 days, inpatient, closely monitored.
- Intentional and temporaryImmune suppression is designed; recovery begins once TIL cells are infused.
Standard Cancer Chemotherapy
- Goal: kill tumor cellsAttacks dividing cancer cells directly, with broad systemic effects.
- Multiple cyclesTypically given over weeks to months in repeated treatment cycles.
- Cumulative toxicitySide effects compound over cycles; hair loss and fatigue are more prolonged.
Planning Considerations Patients Often Overlook
Some phases are inpatient; others are outpatient. If traveling internationally for TIL therapy, expect to be near the treatment center for several weeks during the active phases. Your local oncologist and the treating center should be in active communication throughout โ not operating in parallel silos.
Related TIL Therapy Topics
Continue exploring the CancerFax TIL Therapy guide series.
Frequently Asked Questions
About the TIL Process
How CancerFax Helps
CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.
We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.
We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.
We support appointment coordination, document submission, translation, and direct communication with international departments.
For international patients, we help with practical coordination โ travel planning, hospital admission guidance, and local support.
If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.
From inquiry through to follow-up, our coordinators provide a single point of contact for the family.
CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.
Want to Know If TIL Therapy Fits Your Situation?
Upload your medical reports for a specialist case review. Our team will assess whether TIL therapy is realistically accessible for your specific diagnosis and treatment history.
This content is for informational purposes only and does not constitute medical advice. Always consult a qualified oncologist before making treatment decisions.